Market Overview

Intra-Cellular Therapies Inc. (NYSE: ITCI)

15.37 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2020
Pre-Market
EPS:
REV:




Q3 2020
Pre-Market
EPS:
REV:
-0.63
0



Q2 2020
Pre-Market
EPS:
REV:
-0.68
0



Q1 2020
Pre-Market
EPS:
REV:
-0.63
0



Q4 2019
Pre-Market
EPS:
REV:
-0.75
-0.81
-0.74
60.613K
8.64%
Q3 2019
Pre-Market
EPS:
REV:
-0.76

-0.63
0

Q2 2019
Pre-Market
EPS:
REV:
-0.68
0
-0.83
10K
-0.68
0
18.07%
-100%
Q1 2019
Pre-Market
EPS:
REV:
-0.65
0
-0.87
-0.63
0
27.59%
Q4 2018
Pre-Market
EPS:
REV:
-0.56
5.055K
-0.91
-0.75
-17.58%
Q3 2018
Pre-Market
EPS:
REV:
-0.53
30.754K
-0.84
20K
-0.76
-9.52%
-100%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!